- Report
- March 2024
- 187 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- April 2024
- 184 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- September 2019
- 100 Pages
Global
From €4636EUR$4,795USD£3,982GBP
- Report
- July 2023
- 113 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- February 2024
- 213 Pages
Global
From €3480EUR$3,600USD£2,990GBP
The Lifestyle Drugs market within the context of Anti-Obesity Drugs is a rapidly growing sector of the pharmaceutical industry. These drugs are designed to help individuals lose weight and maintain a healthy lifestyle. They are typically prescribed by a doctor and can be taken orally or injected. Commonly prescribed drugs include Orlistat, Phentermine, and Liraglutide. These drugs work by suppressing appetite, increasing metabolism, and reducing fat absorption. Additionally, lifestyle drugs can help reduce the risk of developing chronic diseases such as diabetes, heart disease, and stroke.
The market for lifestyle drugs is expected to continue to grow as more people become aware of the health benefits associated with them. Additionally, the increasing prevalence of obesity and related health issues is likely to drive demand for these drugs.
Some companies in the market include Novo Nordisk, GlaxoSmithKline, Sanofi, and Orexigen Therapeutics. Show Less Read more
